185 related articles for article (PubMed ID: 9333344)
1. Optimum allocation of treatments for Welch's test in equivalence assessment.
Dette H; Munk A
Biometrics; 1997 Sep; 53(3):1143-50. PubMed ID: 9333344
[TBL] [Abstract][Full Text] [Related]
2. Sample sizes for clinical trials with normal data.
Julious SA
Stat Med; 2004 Jun; 23(12):1921-86. PubMed ID: 15195324
[TBL] [Abstract][Full Text] [Related]
3. Tests for equivalence based on odds ratio for matched-pair design.
Liu JP; Fan HY; Ma MC
J Biopharm Stat; 2005; 15(6):889-901. PubMed ID: 16279349
[TBL] [Abstract][Full Text] [Related]
4. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
Lui KJ; Chang KC
Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
[TBL] [Abstract][Full Text] [Related]
5. Optimal sample sizes for Welch's test under various allocation and cost considerations.
Jan SL; Shieh G
Behav Res Methods; 2011 Dec; 43(4):1014-22. PubMed ID: 21512873
[TBL] [Abstract][Full Text] [Related]
6. Sample size calculation for the Power Model for dose proportionality studies.
Sethuraman VS; Leonov S; Squassante L; Mitchell TR; Hale MD
Pharm Stat; 2007; 6(1):35-41. PubMed ID: 17323313
[TBL] [Abstract][Full Text] [Related]
7. Examining outlying subjects and outlying records in bioequivalence trials.
Wang W; Chow SC
J Biopharm Stat; 2003 Feb; 13(1):43-56. PubMed ID: 12635902
[TBL] [Abstract][Full Text] [Related]
8. Optimal sample sizes for precise interval estimation of Welch's procedure under various allocation and cost considerations.
Shieh G; Jan SL
Behav Res Methods; 2012 Mar; 44(1):202-12. PubMed ID: 21805061
[TBL] [Abstract][Full Text] [Related]
9. Sample size determination: extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43.
Diletti E; Hauschke D; Steinijans VW
Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S59-62. PubMed ID: 1601533
[TBL] [Abstract][Full Text] [Related]
10. Optimum sample size allocation to minimize cost or maximize power for the two-sample trimmed mean test.
Guo JH; Luh WM
Br J Math Stat Psychol; 2009 May; 62(Pt 2):283-98. PubMed ID: 18157920
[TBL] [Abstract][Full Text] [Related]
11. Sample size planning with the cost constraint for testing superiority and equivalence of two independent groups.
Guo JH; Chen HJ; Luh WM
Br J Math Stat Psychol; 2011 Nov; 64(3):439-61. PubMed ID: 20704777
[TBL] [Abstract][Full Text] [Related]
12. Evaluation by simulation of tests based on non-linear mixed-effects models in pharmacokinetic interaction and bioequivalence cross-over trials.
Panhard X; Mentré F
Stat Med; 2005 May; 24(10):1509-24. PubMed ID: 15761916
[TBL] [Abstract][Full Text] [Related]
13. Assessment of selection bias in estimates of relative bioavailability and intrasubject variability from bioequivalence evaluations.
Wang Y
J Biopharm Stat; 2000 Aug; 10(3):407-24. PubMed ID: 10959920
[TBL] [Abstract][Full Text] [Related]
14. In vitro bioequivalence testing.
Chow SC; Shao J; Wang H
Stat Med; 2003 Jan; 22(1):55-68. PubMed ID: 12486751
[TBL] [Abstract][Full Text] [Related]
15. Optimal sample size allocation for Welch's test in one-way heteroscedastic ANOVA.
Shieh G; Jan SL
Behav Res Methods; 2015 Jun; 47(2):374-83. PubMed ID: 24903689
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the reference scaled bioequivalence semi-replicate method with other approaches: focus on human exposure to drugs.
Karalis V; Symillides M; Macheras P
Eur J Pharm Sci; 2009 Aug; 38(1):55-63. PubMed ID: 19524039
[TBL] [Abstract][Full Text] [Related]
17. Power to detect clinically relevant carry-over in a series of cross-over studies.
Putt ME
Stat Med; 2006 Aug; 25(15):2567-86. PubMed ID: 16220475
[TBL] [Abstract][Full Text] [Related]
18. Sample size determination in step-up testing procedures for multiple comparisons with a control.
Kwong KS; Cheung SH; Wen MJ
Stat Med; 2010 Nov; 29(26):2743-56. PubMed ID: 20799258
[TBL] [Abstract][Full Text] [Related]
19. Studies of equivalence in clinical vaccine research.
Jacobson RM; Poland GA
Vaccine; 2005 Mar; 23(17-18):2315-7. PubMed ID: 15755618
[TBL] [Abstract][Full Text] [Related]
20. Sample size determination for comparing several survival curves with unequal allocations.
Halabi S; Singh B
Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
